ABSTRACT
Paul De Lay and co-authors introduce a Collection on the design of targets for ending the AIDS epidemic.
Subject(s)
Acquired Immunodeficiency Syndrome/prevention & control , Disease Eradication/trends , Global Health/trends , Public Health/trends , Acquired Immunodeficiency Syndrome/diagnosis , Acquired Immunodeficiency Syndrome/economics , Acquired Immunodeficiency Syndrome/epidemiology , Disease Eradication/economics , Forecasting , Global Health/economics , Health Care Costs/trends , Humans , Public Health/economics , Time Factors , United NationsABSTRACT
Driven by a mission of justice, Manhattan Plaza and Penn South create beloved communities that care for people at all stages of life.
Subject(s)
Acquired Immunodeficiency Syndrome/therapy , Coronavirus Infections/epidemiology , Housing/organization & administration , Independent Living/statistics & numerical data , Pandemics/statistics & numerical data , Pneumonia, Viral/epidemiology , Social Welfare/economics , Acquired Immunodeficiency Syndrome/diagnosis , Acquired Immunodeficiency Syndrome/epidemiology , Aged , COVID-19 , Female , Geriatric Assessment , Humans , Male , Narration , New York City , Quality of Life , Social Welfare/statistics & numerical data , Socioeconomic FactorsSubject(s)
Acquired Immunodeficiency Syndrome/epidemiology , Coronavirus Infections/epidemiology , Malaria/epidemiology , Pneumonia, Viral/epidemiology , Tuberculosis/epidemiology , Acquired Immunodeficiency Syndrome/diagnosis , Acquired Immunodeficiency Syndrome/drug therapy , COVID-19 , Humans , Malaria/diagnosis , Malaria/drug therapy , Pandemics , Tuberculosis/diagnosis , Tuberculosis/drug therapyABSTRACT
Viral infectious diseases have resulted in millions of deaths throughout history and have created a significant public healthcare burden. Tremendous efforts have been placed by the scientific communities, health officials and government organizations to detect, treat, and prevent viral infection. However, the complicated life cycle and rapid genetic mutations of viruses demand continuous development of novel medicines with high efficacy and safety profiles. Peptides provide a promising outlook as a tool to combat the spread and re-emergence of viral infection. This article provides an overview of five viral infectious diseases with high global prevalence: influenza, chronic hepatitis B, acquired immunodeficiency syndrome, severe acute respiratory syndrome, and coronavirus disease 2019. The current and potential peptide-based therapies, vaccines, and diagnostics for each disease are discussed.